about
Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trialsRepeated treatment for macular edema in vein occlusion by intravitreal implant of dexamethasone.Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion.The ABCs of RVO: a review of retinal venous occlusion.Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusionComparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion.Morphology of optic disc through heidelberg retina tomograph in retinal vein occlusions alone or in combination with primary open angle glaucoma.Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in Branch Retinal Vein Occlusions.Drug and gene delivery to the back of the eye: from bench to bedside.Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective reviewRetinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment.New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionExpression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.Feasibility study on robot-assisted retinal vascular bypass surgery in an ex vivo porcine model.Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.The effects of repeated Ozurdex injections on ocular hypertension.Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
P2860
Q26750459-89EEE894-43FC-427C-978B-F73E4CA8E115Q34471740-C165D6A5-EE46-477E-874F-63F7CA08E0C6Q35038286-5E9205E8-2DF6-4230-AA3E-DD84C0CB0B57Q35047634-27175793-A308-430D-8252-8F4DD2858D7DQ36490483-AE9D5F2D-80E3-49B6-A40F-D90040E0A25DQ36835209-2DF0589A-9A30-4032-A30E-EC16A4557860Q37098557-FF6B59DA-2D89-41C3-A7A4-DF9C935F84B8Q37416461-A3CB5CFB-908E-4B2F-8E63-9D7F7FE05639Q37731899-B79A8E98-133A-49BA-98F4-F44A3498E708Q38364703-1B1AFDF0-9B02-47CE-A175-CC64A5E506FFQ38834085-F74483B3-7EE8-407A-BB95-98E0D0E63397Q38848800-A8791BB7-C9FB-4DF3-AE22-29F88A5CBFA7Q41498626-B7DBEDD0-08A6-44BB-BBB5-7CC94C5C1194Q47809440-62A2E6EC-6F2A-489A-ADAA-777A16A55CF0Q48352897-4974128D-2EC2-45D5-A1CF-219566EDA978Q53829701-1302B5E3-D8A2-4840-B929-7D9203FD0154Q58765745-F9C12B8F-D459-4835-B86A-A46644CE4FE8
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Best practices for treatment of retinal vein occlusion.
@ast
Best practices for treatment of retinal vein occlusion.
@en
Best practices for treatment of retinal vein occlusion.
@nl
type
label
Best practices for treatment of retinal vein occlusion.
@ast
Best practices for treatment of retinal vein occlusion.
@en
Best practices for treatment of retinal vein occlusion.
@nl
prefLabel
Best practices for treatment of retinal vein occlusion.
@ast
Best practices for treatment of retinal vein occlusion.
@en
Best practices for treatment of retinal vein occlusion.
@nl
P1476
Best practices for treatment of retinal vein occlusion
@en
P2093
Sharon Fekrat
P304
P356
10.1097/ICU.0B013E3283524148
P50
P577
2012-05-01T00:00:00Z